Title:
スピロ－ラクタムＮＭＤＡ受容体修飾因子及びその使用
Document Type and Number:
Japanese Patent JP7032378
Kind Code:
B2
Abstract:
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Inventors:
Khan, M., Amin
Application Number:
JP2019505249A
Publication Date:
March 08, 2022
Filing Date:
August 01, 2017
Export Citation:
Assignee:
Aptinix Incorporated
International Classes:
C07D487/10; A61K31/438; A61P25/00; A61P25/04; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P43/00
Domestic Patent References:
| JP2016506962A |
Foreign References:
| WO2007013691A1 |
Attorney, Agent or Firm:
Shinki Global IP Patent Corporation